Tanshinone IIA enhances BMP-2-stimulated commitment of C2C12 cells into osteoblasts via p38 activation

Amino Acids

Volumn 39, Issue 5, 2010, Pages 1217-1226

  Kim, Hye Joo ^a,b   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

BMP; Osteoblast differentiation; p38; Runx2; Smad; Tanshinone IIA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 9; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NOGGIN; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TANSHINONE IIA; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CARRIER PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLES; MICE; MOLECULAR STRUCTURE; OSTEOBLASTS; OSTEOGENESIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENANTHRENES; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

SALVIA MILTIORRHIZA;

EID: 78449304330     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-010-0557-8     Document Type: Article

References (42)

1. PC Bessa MT Cerqueira T Rada ME Gomes NM Neves A Nobre RL Reis M Casal 2009 Expression, purification and osteogenic bioactivity of recombinant human BMP-4, -9, -10, -11 and -14 Protein Expr Purif 63 2 89 94 1:CAS:528: DC%2BD1cXhsVWrsLrK 10.1016/j.pep.2008.09.014 18950713
2. SD Boden TA Zdeblick HS Sandhu SE Heim 2000 The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report Spine 25 3 376 381 1:STN:280:DC%2BD3c7mslOmug%3D%3D 10.1097/00007632-200002010-00020 10703113
3. HJ Chae BJ Jeong MS Ha JK Lee JO Byun WY Jung YG Yun DG Lee SH Oh SW Chae YG Kwak ZH Kim HHm Lee HR Kim 2002 ERK MAP kinase is required in 1, 25(OH)2D3-induced differentiation in human osteoblasts Immunopharmacol Immunotoxicol 24 1 31 41 1:CAS:528:DC%2BD38XktlWmtrc%3D 10.1081/IPH-120003401 12022443
4. D Chen MA Harris G Rossini CR Dunstan SL Dallas JQ Feng GR Mundy SE Harris 1997 Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts Calcif Tissue Int 60 3 283 290 1:CAS:528:DyaK2sXhsFKgsrc%3D 10.1007/s002239900230 9069167
5. H Cheng W Jiang FM Phillips RC Haydon Y Peng L Zhou HH Luu N An B Breyer P Vanichakarn JP Szatkowski JY Park TC He 2003 Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs) J Bone Joint Surg Am 85-A 8 1544 1552 12925636
6. C Christiansen R Lindsay 1990 Estrogens, bone loss and preservation Osteoporos Int 1 1 7 13 1:STN:280:DyaK387mtlKnsg%3D%3D 10.1007/BF01880410 2133643
7. L Cui T Wu YY Liu YF Deng CM Ai HQ Chen 2004 Tanshinone prevents cancellous bone loss induced by ovariectomy in rats Acta Pharmacol Sin 25 5 678 684 1:CAS:528:DC%2BD2cXktV2gsLc%3D 15132837
8. P Ducy G Karsenty 1995 Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene Mol Cell Biol 15 4 1858 1869 1:CAS:528:DyaK2MXksFWjsb4%3D 7891679
9. T Ebisawa K Tada I Kitajima K Tojo TK Sampath M Kawabata K Miyazono T Imamura 1999 Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation J Cell Sci 112 Pt 20 3519 3527 1:CAS:528:DyaK1MXns1Gkt7Y%3D 10504300
10. IR Garrett 2007 Anabolic agents and the bone morphogenetic protein pathway Curr Top Dev Biol 78 127 171 1:CAS:528:DC%2BD2sXmtFKlsbg%3D 10.1016/S0070-2153(06)78004-8 17338916
11. CA Gersbach BA Byers GK Pavlath AJ García 2004 Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype Exp Cell Res 300 2 406 417 1:CAS:528:DC%2BD2cXotlClsrg%3D 10.1016/j.yexcr.2004.07.031 15475005
12. N Ghosh-Choudhury SL Abboud R Nishimura A Celeste L Mahimainathan GG Choudhury 2002 Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription J Biol Chem 277 36 33361 33368 1:CAS:528: DC%2BD38Xnt1SksrY%3D 10.1074/jbc.M205053200 12084724
13. N Ghosh-Choudhury CC Mandal GG Choudhury 2007 Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation J Biol Chem 282 7 4983 4993 1:CAS:528:DC%2BD2sXhsFKgt7g%3D 10.1074/jbc.M606706200 17179158
14. J Guicheux J Lemonnier C Ghayor A Suzuki G Palmer J Caverzasio 2003 Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation J Bone Miner Res 18 11 2060 2068 1:CAS:528:DC%2BD3sXptVyiu7k%3D 10.1359/jbmr.2003.18.11.2060 14606520
15. J Hanai LF Chen T Kanno N Ohtani-Fujita WY Kim WH Guo T Imamura Y Ishidou M Fukuchi MJ Shi J Stavnezer M Kawabata K Miyazono Y Ito 1999 Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter J Biol Chem 274 44 31577 31582 1:CAS:528:DyaK1MXntFOjsr8%3D 10.1074/jbc.274.44.31577 10531362
16. S Harada GA Rodan 2003 Control of osteoblast function and regulation of bone mass Nature 423 6937 349 355 1:CAS:528:DC%2BD3sXjs1ynu7Y%3D 10.1038/nature01660 12748654
17. SI Jang SI Jeong KJ Kim HJ Kim HH Yu R Park HM Kim YO You 2003 Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-α, IL-1β and IL-6 in activated RAW 264.7 cells Planta Med 69 11 1057 1059 1:CAS:528:DC%2BD2cXjvVOisg%3D%3D 10.1055/s-2003-45157 14735448
18. T Katagiri A Yamaguchi M Komaki E Abe N Takahashi T Ikeda V Rosen JM Wozney A Fujisawa-Sehara T Suda 1994 Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage J Cell Biol 127 6 Pt 1 1755 1766 1:CAS:528:DyaK2cXmvFemtLs%3D 10.1083/jcb.127.6.1755 7798324
19. M Kawai K Bessho H Maruyama J Miyazaki T Yamamoto 2006 Simultaneous gene transfer of bone morphogenetic protein (BMP)-2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression BMC Musculoskelet Disord 7 62 10.1186/1471-2474-7-62 16887039
20. Kawamura N, Kugimiya F, Oshima Y, Ohba S, Ikeda T, Saito T, Shinoda Y, Kawasaki Y, Ogata N, Hoshi K, Akiyama T, Chen WS, Hay N, Tobe K, Kadowaki T, Azuma Y, Tanaka S, Nakamura K, Chung UI, Kawaguchi H (2007) Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS ONE 2:e1058
21. HJ Kim HD Park JH Kim JY Cho JY Choi JK Kim HJ Kim HI Shin HM Ryoo 2004 Establishment and characterization of a stable cell line to evaluate cellular Runx2 activity J Cell Biochem 91 6 1239 1247 1:CAS:528:DC%2BD2cXjt1ynt78%3D 10.1002/jcb.20038 15048877
22. HK Kim ER Woo HW Lee HR Park HN Kim YK Jung JY Choi SW Chae HR Kim HJ Chae 2008 The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone Immunopharmacol Immunotoxicol 30 2 347 364 1:CAS:528:DC%2BD1cXnsFartrk%3D 10.1080/08923970801949133 18569089
23. HB Kwak HM Sun H Ha HN Kim JH Lee HH Kim HI Shin ZH Lee 2008 Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts Eur J Pharmacol 601 1-3 30 37 1:CAS:528:DC%2BD1cXhsVKrsbrL 10.1016/j.ejphar.2008.10.034 18973753
24. SY Lee DY Choi ER Woo 2005 Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza bunge Arch Pharm Res 28 8 909 913 1:CAS:528:DC%2BD2MXhtVSktrbL 10.1007/BF02973876 16178416
25. JZ Li H Li T Sasaki D Holman B Beres RJ Dumont DD Pittman GR Hankins GA Helm 2003 Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat Gene Ther 10 20 1735 1743 1:CAS:528:DC%2BD3sXms1Crtbk%3D 10.1038/sj.gt.3302075 12939640
26. JB Lian JL Stein GS Stein AJ van Wijnen M Montecino A Javed S Gutierrez J Shen SK Zaidi H Drissi 2003 Runx2/Cbfa1 functions: diverse regulation of gene transcription by chromatin remodeling and co-regulatory protein interactions Connect Tissue Res 44 Suppl 1 141 148 1:CAS:528:DC%2BD3sXjtlamsb8%3D 12952188
27. -ΔΔCT method Methods 25 4 402 408 1:CAS:528:DC%2BD38XhtFelt7s%3D 10.1006/meth.2001.1262 11846609
28. HL Merriman AJ van Wijnen S Hiebert JP Bidwell E Fey J Lian J Stein GS Stein 1995 The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter Biochemistry 34 40 13125 13132 1:CAS:528: DyaK2MXotVyrt7k%3D 10.1021/bi00040a025 7548073
29. G Mundy R Garrett S Harris J Chan D Chen G Rossini B Boyce M Zhao G Gutierrez 1999 Stimulation of bone formation in vitro and in rodents by statins Science 286 5446 1946 1949 1:CAS:528:DyaK1MXnvFSiu78%3D 10.1126/science.286. 5446.1946 10583956
30. M Nakashima AH Reddi 2003 The application of bone morphogenetic proteins to dental tissue engineering Nat Biotechnol 21 9 1025 1032 1:CAS:528: DC%2BD3sXmslCrsro%3D 10.1038/nbt864 12949568
31. A Nohe S Hassel M Ehrlich F Neubauer W Sebald YI Henis P Knaus 2002 The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways J Biol Chem 277 7 5330 5338 1:CAS:528:DC%2BD38XhsFCjsLc%3D 10.1074/jbc.M102750200 11714695
32. M Phimphilai Z Zhao H Boules H Roca RT Franceschi 2006 BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype J Bone Miner Res 21 4 637 646 1:CAS:528:DC%2BD28Xkt1Kqs7s%3D 10.1359/jbmr.060109 16598384
33. BL Riggs LC Hartmann 2003 Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice N Engl J Med 348 7 618 629 1:CAS:528:DC%2BD3sXhtVyqtLs%3D 10.1056/NEJMra022219 12584371
34. GA Rodan TJ Martin 2000 Therapeutic approaches to bone diseases Science 289 5484 1508 1514 1:CAS:528:DC%2BD3cXmt1Kgsb4%3D 10.1126/science.289.5484.1508 10968781
35. S Rozen HJ Skaletsky 2000 Primer3 on the WWW for general users and for biologist programmers Methods Mol Biol 132 365 386 1:CAS:528:DyaK1MXmslKqsbo%3D 10547847
36. H Seeherman JM Wozney 2005 Delivery of bone morphogenetic proteins for orthopedic tissue regeneration Cytokine Growth Factor Rev 16 3 329 345 1:CAS:528:DC%2BD2MXlsl2rtb4%3D 10.1016/j.cytogfr.2005.05.001 15936978
37. A Suzuki J Guicheux G Palmer Y Miura Y Oiso JP Bonjour J Caverzasio 2002 Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation Bone 30 1 91 98 1:CAS:528: DC%2BD38XktFequw%3D%3D 10.1016/S8756-3282(01)00660-3 11792570
38. K Takayama A Suzuki T Manaka S Taguchi Y Hashimoto Y Imai S Wakitani K Takaoka 2009 RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro J Bone Miner Metab 27 4 402 411 1:CAS:528:DC%2BD1MXnvValtrc%3D 10.1007/s00774-009-0054-x 19252814
39. A Valentin-Opran J Wozney C Csimma L Lilly GE Riedel 2002 Clinical evaluation of recombinant human bone morphogenetic protein-2 Clin Orthop Relat Res 395 110 120 10.1097/00003086-200202000-00011 11937870
40. M van der Klift CD de Laet HA Pols 2005 Assessment of fracture risk: who should be treated for osteoporosis? Best Pract Res Clin Rheumatol 19 6 937 950 10.1016/j.berh.2005.06.001 16301188
41. X Wang Y Wei S Yuan G Liu Y Lu J Zhang W Wang 2005 Potential anticancer activity of tanshinone IIA against human breast cancer Int J Cancer 116 5 799 807 1:CAS:528:DC%2BD2MXosVaqtbk%3D 10.1002/ijc.20880 15849732
42. LC Yeh AD Tsai JC Lee 2002 Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12 J Cell Biochem 87 3 292 304 1:CAS:528:DC%2BD38XosFymu74%3D 10.1002/jcb.10315 12397611